News
![Holding(s)in company](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Holding(s)in company
Holding(s)in company
![DGAP-News: Wacker Chemie AG: WACKER Sets New Corporate Sustainability Goals](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
DGAP-News: Wacker Chemie AG: WACKER Sets New Corporate Sustainability Goals
DGAP-News: Wacker Chemie AG: WACKER Sets New Corporate Sustainability Goals
![DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad participates in NewtonX's $32m Series B funding round](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad participates in NewtonX's $32m Series B funding round
DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad participates in NewtonX's $32m Series B funding round
![Lyxor International Asset Management: DELISTINGS - 9 shares classes - London Stock Exchange](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Lyxor International Asset Management: DELISTINGS - 9 shares classes - London Stock Exchange
Lyxor International Asset Management: DELISTINGS - 9 shares classes - London Stock Exchange
![DGAP-News: Knaus Tabbert AG: Knaus Tabbert AG strengthens financial flexibility](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
DGAP-News: Knaus Tabbert AG: Knaus Tabbert AG strengthens financial flexibility
DGAP-News: Knaus Tabbert AG: Knaus Tabbert AG strengthens financial flexibility
![Petrofac Limited: Trading Update](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Petrofac Limited: Trading Update
Petrofac Limited: Trading Update
![Biophytis to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia from Phase 2 to Phase 3](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Biophytis to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia from Phase 2 to Phase 3
Biophytis to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia from Phase 2 to Phase 3
![Samarkand Group plc : Interim Results](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Samarkand Group plc : Interim Results
Samarkand Group plc : Interim Results
![Travis Perkins: Transaction in Own Shares](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
![DGAP-News: VIB Vermögen AG: Joint Venture VIB/WDP rents out 46.000 sqm in Gelsenkirchen](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
DGAP-News: VIB Vermögen AG: Joint Venture VIB/WDP rents out 46.000 sqm in Gelsenkirchen
DGAP-News: VIB Vermögen AG: Joint Venture VIB/WDP rents out 46.000 sqm in Gelsenkirchen
![DGAP-News: APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
DGAP-News: APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO
DGAP-News: APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO
![DGAP-News: Deutsche Konsum REIT-AG with successful completion of the 2020/2021 financial year](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
DGAP-News: Deutsche Konsum REIT-AG with successful completion of the 2020/2021 financial year
DGAP-News: Deutsche Konsum REIT-AG with successful completion of the 2020/2021 financial year
![EQS-News: Straumann Group presents evolved strategy to achieve its long-term revenue ambition of CHF 5 billion](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
EQS-News: Straumann Group presents evolved strategy to achieve its long-term revenue ambition of CHF 5 billion
EQS-News: Straumann Group presents evolved strategy to achieve its long-term revenue ambition of CHF 5 billion
![EQS-Adhoc: Relief Therapeutics Files Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
EQS-Adhoc: Relief Therapeutics Files Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
EQS-Adhoc: Relief Therapeutics Files Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
![DGAP-News: SHOP APOTHEKE EUROPE Launches its Own Marketplace.](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
DGAP-News: SHOP APOTHEKE EUROPE Launches its Own Marketplace.
DGAP-News: SHOP APOTHEKE EUROPE Launches its Own Marketplace.
![EQS-Adhoc: Swiss Prime Site acquires Zug-based Akara Group](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
EQS-Adhoc: Swiss Prime Site acquires Zug-based Akara Group
EQS-Adhoc: Swiss Prime Site acquires Zug-based Akara Group
![Form 8 (DD) - Paul Zwillenberg PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Form 8 (DD) - Paul Zwillenberg PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT
Form 8 (DD) - Paul Zwillenberg PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT
![DGAP-News: Abivax to present at the J.P. Morgan 40th Annual Healthcare Conference](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
DGAP-News: Abivax to present at the J.P. Morgan 40th Annual Healthcare Conference
DGAP-News: Abivax to present at the J.P. Morgan 40th Annual Healthcare Conference
![DGAP-News: Vita 34 presents itself in new size for the first time at the Annual General Meeting 2021](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
DGAP-News: Vita 34 presents itself in new size for the first time at the Annual General Meeting 2021
DGAP-News: Vita 34 presents itself in new size for the first time at the Annual General Meeting 2021
![Rights and Issues Investment Trust PLC: Transaction in Own Shares](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: Transaction in Own Shares
![Lyxor International Asset Management: Lyxor ETF - NAV publication issue for LSE listed ETFs](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Lyxor International Asset Management: Lyxor ETF - NAV publication issue for LSE listed ETFs
Lyxor International Asset Management: Lyxor ETF - NAV publication issue for LSE listed ETFs
![EQS-News: Sensirion Holding AG: VOC+NOx sensor for indoor air quality applications is now available worldwide](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
EQS-News: Sensirion Holding AG: VOC+NOx sensor for indoor air quality applications is now available worldwide
EQS-News: Sensirion Holding AG: VOC+NOx sensor for indoor air quality applications is now available worldwide
![DGAP-News: FYI Resources: OUTSTANDING RESULTS FROM JOINT HPA TRIAL](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
DGAP-News: FYI Resources: OUTSTANDING RESULTS FROM JOINT HPA TRIAL
DGAP-News: FYI Resources: OUTSTANDING RESULTS FROM JOINT HPA TRIAL
![DGAP-News: Mynaric receives 2021 Pioneer Space Business Award of the Year from Euroconsult](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
DGAP-News: Mynaric receives 2021 Pioneer Space Business Award of the Year from Euroconsult
DGAP-News: Mynaric receives 2021 Pioneer Space Business Award of the Year from Euroconsult
![HMS Group Reports Rub 5.2 billion EBITDA for 9 months 2021](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
HMS Group Reports Rub 5.2 billion EBITDA for 9 months 2021
HMS Group Reports Rub 5.2 billion EBITDA for 9 months 2021